The Acceptance, Safety, and Efficacy of MadaJet Versus Needle Injection for Sperm Retrieval in Patients With Azoospermia

Male Infertility Clinical Trial

Official title:

The Acceptance, Safety, and Efficacy of Needle-free Jet Anaesthetic Technique (MadaJet) Versus Needle Injection for Sperm Retrieval in Patients With Azoospermia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03181243
• Other study ID #: NCKH/CGRH_03_2017
• Status: Completed
• Phase: N/A
• First received: June 2, 2017
• Last updated: December 29, 2017
• Start date: July 15, 2017
• Est. completion date: December 25, 2017

Study information

• Verified date: December 2017
• Source: Vietnam National University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To compare the acceptance, safety, and efficacy of needle-free jet anaesthetic technique (MadaJet) versus needle injection for sperm retrieval in patients with azoospermia.

Description:

Azoospermia is found in 1-3% of general population and 10-15% of men presenting with infertility. In this scenario, there are no spermatozoa in the patient's semen after centrifugation, and pregnancy may be achieved through IVF/ Intracytoplasmic sperm injection (ICSI) combined with sperm retrieval techniques (e.g. PESA, testicular sperm extraction - TESE, TESA). These techniques are commonly conducted under local anesthesia, which a 10-15 mL solution of 2% lidocaine hydrochloride injected around the spermatic cord near the external inguinal ring. However, needle fear is prevalent in both children (~33-63%) and adults (~14-38%) and can contribute to negative experiences with needle procedures and health care for patients, caregivers, and health professionals. In clinical practice, patients often concern about the pain, trauma and possible complication (i.e. wheal, hematoma, infection) of needle injection of local anaesthesia into and through the scrotal wall when performing sperm retrieval. It not only interferes with clinicians' abilities to carry out procedures (e.g. due to flailing and attempts to escape), but also undermines the efficacy of pain interventions at the time of the needle. Therefore, receiving local anaesthesia without a needle is easily well accepted by the patients with azoospermia.

The needleless jet injector (MadaJet Medical Injector) has been widely used in the fields of dermatology, cosmetic and plastic surgery, gynecology, dentistry, and podiatry as well as for immunization. It was also employed for no-scalpel vasectomy in Urology/Andrology. The first studies using needleless jet injector for spermatic cord block was reported by Wilson in 2001 and Weiss in 2005. The next studies showed that MadaJet has better outcomes (e.g. cost, pain scores, onset time) than traditional needle anaesthesia (16-18). Unlike a conventional spermatic cord block with needle injection, there is no wheal on the patients' skin and local edema after administering injection. A mist of solution with a high-pressure injector will be rapidly delivered and absorbed through the skin to the tissue beneath around the cord with much less trauma. As a consequence, it is less painful than the needle injection.

For those reasons, a needle-free jet anaesthetic technique for sperm retrieval will be described for local anaesthesia, which may minimize the fear of the needle. The acceptance, safety, and efficacy of this technique will also be compared with needle injection for sperm retrieval in azoospermia patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: December 25, 2017
• Est. primary completion date: December 25, 2017
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 20 Years to 100 Years

Eligibility

Inclusion Criteria:

• Patients (including obstructive azoospermia and non-obstructive azoospermia) in need of sperm retrieval (PESA, TESE) for ICSI.

Exclusion Criteria:

• Have not finished the process of sperm retrieval techniques.

• Malformation of genital organs (e.g. spermatic cord, testicle)

• Anxious, alcoholic patients.

• Patients giving a history of personality disorders.

• Patients who abuse drugs.

• Disagree to participate in the study.

Related Conditions & MeSH terms

• Azoospermia
• Infertility
• Infertility, Male
• Male Infertility

Intervention

Procedure:
• Madajet
The spermatic cord is firmly trapped between the middle finger, index finger and thumb of the left hand. The injector's sheath is placed over the spermatic cord with gentle pressure adjacent to the external inguinal ring. Depending upon the thickness of spermatic cord, three or four injections are consecutively administered around it, beginning from proximal to distal points.
• Needle injection
The pubic tubercle is palpated on the side that is going to be blocked. The spermatic cord is then immobilised with the non-dominant hand between the thumb and index finger. Right after needle puncture with attached syringe and local anaesthetic solution is conducted at a point that is 1 cm inferior to and 1 cm medial to the pubic tubercle, pass the needle directly downward in a vertical fashion, which leads it into the spermatic cord. After a check-up (negative aspiration) for bleeding, approximately 3 mL of solution (Lidocaine 2%) is injected into the cord.

Locations

Country	Name	City	State
Vietnam	My Duc Hospital	Ho Chi Minh City

Sponsors (1)

Lead Sponsor	Collaborator
Vietnam National University

Country where clinical trial is conducted

Vietnam, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain score	Right after completing the injection, information about the pain before, during and after the sperm retrieval technique will be immediately documented by the visual analog scale (VAS) questionnaire on 10 cm lines (0 represents no pain, whereas 10 marks the highest score).	1 year
Secondary	Pressure (fear) of the patients	Right after completing the injection, information about the pain before, during and after the sperm retrieval technique will be immediately documented by the visual analog scale (VAS) questionnaire on 10 cm lines (0 represents no pain, whereas 10 marks the highest score).	1 year
Secondary	Discomfort of the patients	Right after completing the injection, information about the pain before, during and after the sperm retrieval technique will be immediately documented by the visual analog scale (VAS) questionnaire on 10 cm lines (0 represents no pain, whereas 10 marks the highest score).	1 year
Secondary	Incidence of treatment (Bleeding)	Bleeding will be recorded peri- and post- operative anesthesia.	1 year
Secondary	Incidence of treatment (Swelling)	Swelling will be recorded peri- and post- operative anesthesia.	1 year
Secondary	Incidence of treatment (Hematoma)	Hematoma will be recorded peri- and post- operative anesthesia.	1 year
Secondary	Onset of action of Madajet	By using the stopwatch, the onset of action of anesthesia will be recorded. Every five seconds, the pain reaction which shows the onset is determined on the scrotum by using tissue forceps.	1 year
Secondary	Duration of action of Madajet	By using the stopwatch, the duration of action of anesthesia will be recorded. The patients are observed in the operation room until all the symptoms of anesthesia wore off. The total duration of anesthesia is measured from the time of onset until the patient reports normal reaction in the scrotum.	1 year
Secondary	Onset of action of Needle injection	By using the stopwatch, the onset of action of anesthesia will be recorded. Every thirty seconds, the pain reaction which shows the onset is determined on the scrotum by using tissue forceps.	1 year
Secondary	Duration of action of Needle injection	By using the stopwatch, the duration of action of anesthesia will be recorded. The patients are observed in the operation room until all the symptoms of anesthesia wore off. The total duration of anesthesia is measured from the time of onset until the patient reports normal reaction in the scrotum.	1 year